The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy

被引:36
|
作者
Beresford, M
Glynne-Jones, R
Richman, P
Makris, A
Mawdsley, S
Stott, D
Harrison, M
Osborne, M
Ashford, R
Grainger, J
Al-Jabbour, J
Talbot, I
Mitchell, IC
Thomas, JM
Livingstone, JI
McCue, J
MacDonald, P
Northover, JAM
Windsor, A
Novell, R
Wallace, M
Harrison, RA
机构
[1] Mt Vernon Canc Ctr, Northwood, Middx, England
[2] Univ Hertfordshire, HRDSU, Hatfield AL10 9AB, Herts, England
[3] Barnet Hosp, Barnet, Herts, England
[4] Watford Dist Gen Hosp, Watford, Herts, England
[5] St Marks Hosp, Harrow, Middx, England
[6] Queen Elizabeth II Hosp, Welwyn Garden City, Herts, England
[7] Luton & Dunstable Hosp, Luton, Herts, England
关键词
chemoradiation; lymph nodes; rectal adenocarcinoma;
D O I
10.1016/j.clon.2005.05.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: To determine the prognostic significance of the nodal stage and number of nodes recovered in the surgical specimen after preoperative synchronous chemoradiation (SCRT) and surgery for locally advanced or unresectable rectal cancer. Materials and Methods: One hundred and eighty-two consecutive patients with locally advanced or unresectable (T3/T4) rectal carcinomas were entered on a prospective database and treated in this department with preoperative chemoradiation, followed 6-12 weeks later by surgical resection. Most patients received chemotherapy in the form of low-dose folinic acid and 5-fluorouracil (5-FU) 350 mg/m(2) via a 60-min infusion on days 1-5 and 29-33 of a course of pelvic radiotherapy delivered at a dose of 45 Gy in 25 fractions over 33 days to a planned volume. After resection, patients with a positive circumferential margin (<= 1 mm), extranodal deposits or Dukes' C histology received adjuvant 5-FU-based-chemotherapy (n = 40). Results: After SCRT, 161 patients underwent resection. Twenty-one patients remained unresectable or refused an exenterative operation. Median follow-up is 36 months. Down-staging was achieved in most patients, with 19 having a complete pathological response (pT0). The median number of lymph nodes recovered for all patients was five (range 0-21). The 3-year survival rate for node-positive patients is 47%, for node-negative patients with less than three lymph nodes recovered is 62% and for node-negative patients with three or more lymph nodes recovered is 70%. Compared with node-positive patients, simple regression models revealed a reduced hazard ratio (HR) of 0.72 (0.36-1.43) for node-negative patients with less than three nodes recovered and 0.48 (0.26-0.89) for node-negative patients with three or more lymph nodes recovered. In a multivariate model, including nodal status, excision status, age and sex only positive excision margins significantly predicted a poor outcome: HR = 3.05 (1.55-5.97). Conclusions: The number of nodes found after preoperative chemoradiation is a significant prognostic factor by univariate analysis. In this study, patients with node-negative histology, and at least three nodes recovered, had better long-term survival than patients in whom two or less nodes were recovered or with positive nodes. This effect was attenuated by the inclusion of excision status in multivariate models.
引用
收藏
页码:448 / 455
页数:8
相关论文
共 50 条
  • [1] Lymph Node Retrieval after Preoperative Chemoradiotherapy for Rectal Cancer
    Daniel C. Damin
    Mário A. Rosito
    Paulo C. Contu
    Cláudio Tarta
    Paulo R. Ferreira
    Lucia M. Kliemann
    Gilberto Schwartsmann
    [J]. Journal of Gastrointestinal Surgery, 2012, 16 : 1573 - 1580
  • [2] Lymph Node Retrieval after Preoperative Chemoradiotherapy for Rectal Cancer
    Damin, Daniel C.
    Rosito, Mario A.
    Contu, Paulo C.
    Tarta, Claudio
    Ferreira, Paulo R.
    Kliemann, Lucia M.
    Schwartsmann, Gilberto
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (08) : 1573 - 1580
  • [3] Lymph node retrieval after resection of rectal cancer following preoperative chemoradiotherapy
    Latkauskas, Tadas
    Lizdenis, Paulius
    Janciauskiene, Rasa
    Pranys, Darius
    Tamelis, Algimantas
    Pavalkis, Dainius
    [J]. MEDICINA-LITHUANIA, 2010, 46 (05): : 299 - 304
  • [4] Preoperative Submucosal Injection of Carbon Nanoparticles Improves Lymph Node Staging Accuracy in Rectal Cancer after Neoadjuvant Chemoradiotherapy
    Wang, Yanan
    Deng, Haijun
    Chen, Hongyuan
    Liu, Hao
    Xue, Qi
    Yan, Jun
    Li, Guoxin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 221 (05) : 923 - 930
  • [5] The Effects of Preoperative Chemoradiotherapy on Lymph Node Sampling in Rectal Cancer
    Miller, Eric D.
    Robb, Bruce W.
    Cummings, Oscar W.
    Johnstone, Peter A. S.
    [J]. DISEASES OF THE COLON & RECTUM, 2012, 55 (09) : 1002 - 1007
  • [6] Lymph node status as a prognostic indicator after preoperative neoadjuvant chemoradiotherapy of rectal cancer
    Mirbagheri, N.
    Kumar, B.
    Deb, S.
    Poh, B. R.
    Dark, J. G.
    Leow, C. C.
    Teoh, W. M. K.
    [J]. COLORECTAL DISEASE, 2014, 16 (10) : O339 - O346
  • [7] Usefulness of the Addition of Lymph Node Ratio to the 2010 Staging System for Rectal Cancer Treated with Preoperative Chemoradiotherapy
    Luna-Perez, P.
    Ramirez, M.
    Salazar, N.
    Cravioto, A.
    Rodriguez, S.
    Gutierrez, M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S73 - S73
  • [8] Preoperative lymph node staging in rectal cancer: A difficult challenge
    Detry, RJ
    Kartheuser, AH
    Lagneaux, G
    Rahier, J
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1996, 11 (05) : 217 - 221
  • [9] Lymph node yield in rectal cancer surgery: Effect of preoperative chemoradiotherapy
    Morcos, B.
    Baker, B.
    Al Masri, M.
    Haddad, H.
    Hashem, S.
    [J]. EJSO, 2010, 36 (04): : 345 - 349
  • [10] Oncological Impact of Lateral Lymph Node Dissection After Preoperative Chemoradiotherapy in Patients with Rectal Cancer
    Min Jung Kim
    George J. Chang
    Han-Ki Lim
    Mi Kyung Song
    Sung Chan Park
    Dae Kyung Sohn
    Hee Jin Chang
    Dae Yong Kim
    Ji Won Park
    Seung-Yong Jeong
    Jae Hwan Oh
    [J]. Annals of Surgical Oncology, 2020, 27 : 3525 - 3533